CRISPR Therapeutics AG

NASDAQ: CRSP · Real-Time Price · USD
59.85
1.03 (1.75%)
At close: Aug 15, 2025, 1:29 PM

CRISPR Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-9.07 -32.28 -4.86 15.24
PEG Ratio
-0.07 0.42 0.02 -0.08
PS Ratio
94.87 13.36 7.25K 6.30
PB Ratio
1.72 2.63 1.69 2.40
P/FCF Ratio
-22.95 -18.21 -5.93 12.59
P/OCF Ratio
-23.26 -19.05 -6.38 10.68
OCF/S Ratio
-4.08 -0.7 -1.14K 0.59
Debt / Equity Ratio
0.12 0.13 0.13 0.09
Quick Ratio
22.07 17.54 15.39 20.17
Current Ratio
22.07 17.54 15.30 20.17
Asset Turnover
0.02 0.17 0.00 0.33
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.19 -0.08 -0.35 0.16
Return on Assets
-0.16 -0.07 -0.29 0.14
Return on Invested Capital
-0.22 -0.1 -0.31 0.14
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
-2.15 0.65 -251.87 0.98
Net Profit Margin
-10.46 -0.41 -1.49K 0.41
Pretax Profit Margin
-10.36 -0.41 -1.49K 0.42
Operating Profit Margin
-13.33 -0.6 -1.54K 0.41
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-12.78 -0.55 -1.49K 0.43